Off-Label Prosecutions Hinge On Patient Benefit, Government Attorneys Say

Federal prosecutors say they will not pursue False Claims Act cases in which off-label use is the standard of care and note that the Caronia decision will have little impact on investigations; First Amendment defense fails in Par and Harkonen cases.